Your browser doesn't support javascript.
Generalized bullous fixed drug eruption after Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccination.
Wantavornprasert, K; Noppakun, N; Klaewsongkram, J; Rerknimitr, P.
  • Wantavornprasert K; Division of Dermatology, Skin and Allergy Research Unit, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Noppakun N; Division of Dermatology, Skin and Allergy Research Unit, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Klaewsongkram J; Division of Allergy and Clinical Immunology, Skin and Allergy Research Unit, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Rerknimitr P; Division of Dermatology, Skin and Allergy Research Unit, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Clin Exp Dermatol ; 47(2): 428-432, 2022 02.
Article in English | MEDLINE | ID: covidwho-1462752

Full text: Available Collection: International databases Database: MEDLINE Main subject: Drug Eruptions / COVID-19 / ChAdOx1 nCoV-19 Type of study: Case report Topics: Vaccines Limits: Aged / Humans / Male Language: English Journal: Clin Exp Dermatol Year: 2022 Document Type: Article Affiliation country: Ced.14926

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Drug Eruptions / COVID-19 / ChAdOx1 nCoV-19 Type of study: Case report Topics: Vaccines Limits: Aged / Humans / Male Language: English Journal: Clin Exp Dermatol Year: 2022 Document Type: Article Affiliation country: Ced.14926